Postmarketing Commitments: Sponsors Often Do Not Publish Results Of New Clinical Trials
Executive Summary
Only 15% of postmarketing commitments for drugs approved in 2009-2012 were for clinical trials and only half of these were published, study finds; authors call for US FDA to provide more trial information.